Send me a link:

*Text messaging rates may apply.

 Dow Down1.88% Nasdaq Down2.09%

KaloBios Pharmaceuticals, Inc. (KBIO)

-NasdaqGM
1.65 Jul 31, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Total Revenue 44   6,098   20,255  
Cost of Revenue -   -   -  
Gross Profit 44   6,098   20,255  
Operating Expenses
Research Development32,640  24,519  18,512  
Selling General and Administrative8,313  5,061  4,010  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (40,909) (23,482) (2,267)
Income from Continuing Operations
Total Other Income/Expenses Net47  157  35  
Earnings Before Interest And Taxes(40,862)(23,325)(2,232)
Interest Expense1,086  184   -  
Income Before Tax(41,948)(23,509)(2,232)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(41,948)(23,509)(2,232)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (41,948) (23,509) (2,232)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (41,948) (23,509) (2,232)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.